[SYRE] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -18.73%
YoY- -26.23%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 2,378 1,510 1,482 1,261 1,479 982 1,247 53.96%
PBT -9,414 -8,119 -6,483 -7,874 -6,632 -6,247 -5,483 43.52%
Tax 0 0 0 0 0 0 0 -
NP -9,414 -8,119 -6,483 -7,874 -6,632 -6,247 -5,483 43.52%
Tax Rate - - - - - - - -
Total Cost 11,792 9,629 7,965 9,135 8,111 7,229 6,730 45.48%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -395.88 -537.68 -437.45 -624.43 -448.41 -636.15 -439.70 -6.77%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -11.43 -12.17 0.00 -12.00 -11.75 -11.68 0.00 -
EPS Diluted -11.43 -12.17 0.00 -12.00 -11.75 -11.68 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.